4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-030693
Options or other derivatives
- President & CEO acquired 182,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Stonehouse Jon P President & CEO | 2020-12-03 | Grant or award · Emp. Stock Option (Right to Buy) | +25,000 | 25,000 | D: show line 1 in the form | |||||
| Stonehouse Jon P President & CEO | 2020-12-03 | Grant or award · Emp. Stock Option (Right to Buy) | +157,250 | 157,250 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…